Hypoglycemic Agents: all 3,927 studies that test it
Page 32 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Investigating the Accuracy of the Home Glucose Monitors in HypoglycemiaCompletedNCT01013402Phase 4
- Third-line Therapy of Multiple Myeloma a Prospective Phase I /II TrialStatus unknownNCT01010243Phase 1/2
- Drug Interaction Between CKD-501 and MetforminCompletedNCT01005160Phase 1
- Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted StateCompletedNCT01002807Phase 1
- Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 DiabeticsCompletedNCT01002768Phase 1
- Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II DiabeticsStatus unknownNCT01001962Phase 4
- Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male SubjectsCompletedNCT01001013Phase 1
- A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin LisproCompletedNCT01000922Phase 2
- Vildagliptin and Endothelium-dependent VasodilatationCompletedNCT01000688Phase 3
- The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney DiseaseStatus unknownNCT01000545Phase 3
- The Effects of Metformin on Pregnancy and Miscarriage Rates in Polycystic Ovary Syndrome (PCOS)CompletedNCT00994812Phase 3
- Investigation of the Response Relationship of NN5401 in Type 1 DiabeticsCompletedNCT00993096Phase 1
- Efficiency of Two Glucose Sampling Protocols for Maintenance of EuglycemiaCompletedNCT00993057Early Phase 1
- Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 DiabeticsCompletedNCT00992537Phase 1
- Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 DiabetesStatus unknownNCT00991055Phase 4
- Topiramate Augmentation in Bulimia Nervosa Partial RespondersWithdrawnNCT00988481Phase 4
- Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary SyndromeStatus unknownNCT00988078Not applicable
- A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective DisordersCompletedNCT00986336Phase 1
- A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder PatientsCompletedNCT00986128Phase 1
- Hyperglycemia in a Coronary Intensive Care UnitCompletedNCT00984737Not applicable
- Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 DiabetesCompletedNCT00982254Phase 1
- Pioglitazone in Alzheimer DiseaseCompletedNCT00982202Phase 2
- Vildagliptin in New Onset Diabetes After TransplantationCompletedNCT00980356Phase 2
- Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 DiabetesCompletedNCT00978796Phase 4
- Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 DiabetesCompletedNCT00978263Not applicable
- Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT00975065Phase 4
- A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)CompletedNCT00975052Phase 1
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 DiabetesCompletedNCT00971659Phase 1
- Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy VolunteersCompletedNCT00969592Phase 1
- Predictive Parameters for Efficacy of Sitagliptin and Metformin CombinationCompletedNCT00969566Phase 4
- Effect of Sitagliptin on Endothelial Progenitor CellsCompletedNCT00968006Phase 4
- Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)TerminatedNCT00967642Not applicable
- Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsCompletedNCT00965549Phase 4
- Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes MellitusCompletedNCT00964574Phase 4
- Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study PopulationCompletedNCT00964184Phase 4
- Validation Study of Multiple Probe Compounds for Drug Interaction EvaluationCompletedNCT00964106Phase 1
- Effect of Sitagliptin in Impaired Glucose ToleranceStatus unknownNCT00961363Phase 2
- A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 DiabetesCompletedNCT00961324Phase 1
- Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of SitagliptinCompletedNCT00960453Phase 1
- Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes PatientsCompletedNCT00957060Phase 4
- Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) LipoproteinsCompletedNCT00953498Phase 4
- Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) PatientsCompletedNCT00953355Phase 4
- The Effects of LAF237 on Gastric Function in Type 2 DiabetesCompletedNCT00952991Phase 3
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 DiabetesCompletedNCT00950677Phase 4
- Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary CareTerminatedNCT00950534Phase 4
- Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) TreatmentCompletedNCT00949442Phase 4
- PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral ContraceptivesCompletedNCT00948402Phase 3
- To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol TabletsCompletedNCT00946504Phase 1
- Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult SubjectsCompletedNCT00944346Phase 1
- Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult SubjectsCompletedNCT00944177Phase 1
- Intensive Glycemic Control on Infectious Morbidity In Patients With Acute LeukemiaWithdrawnNCT00943709Phase 3
- Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes PatientsCompletedNCT00941369Phase 4
- Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)CompletedNCT00941239Phase 1
- Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With MetforminCompletedNCT00941148Phase 4
- Effect of Sitagliptin on Postprandial Lipoprotein MetabolismTerminatedNCT00939939Phase 4
- Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).WithdrawnNCT00936234Phase 2/3
- Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)WithdrawnNCT00935363Phase 1
- Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 DiabetesCompletedNCT00934414Phase 2
- AZD2066 Cocktail StudyCompletedNCT00930306Phase 1
- Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult ControlsCompletedNCT00927524Not applicable
- Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin ResistanceTerminatedNCT00927290Phase 3
- Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/RibaCompletedNCT00926614Phase 4
- The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic SyndromeCompletedNCT00926341Phase 4
- Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 SubjectsCompletedNCT00926016Not applicable
- Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of GlimepirideCompletedNCT00924573Phase 3
- Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00919555Phase 1/2
- Evaluation Study of New Compounds With Potential Use in SchizophreniaWithdrawnNCT00916201Phase 1
- Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer PatientsCompletedNCT00909506Phase 2
- Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)CompletedNCT00908921Phase 4
- Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart InsulinWithdrawnNCT00906529Phase 4
- Pathophysiology of Uric Acid NephrolithiasisCompletedNCT00904046Not applicable
- Bioequivalence Study of Topiramate Tablets 25mg Under Fed ConditionsCompletedNCT00902473Not applicable
- Bioequivalence Study of Topiramate Tablets 25mg Under Fasting ConditionsCompletedNCT00901784Not applicable
- Clinical and Biologic Effects of Metformin in Early Stage Breast CancerCompletedNCT00897884Not applicable
- Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart FailureCompletedNCT00894868Phase 4
- Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide TherapyCompletedNCT00892073Phase 2
- Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese AdolescentsTerminatedNCT00889876Not applicable
- Metformin and Gestational Diabetes in High-risk Patients: a RCTsStatus unknownNCT00883259Phase 4
- To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting ConditionsCompletedNCT00882882Phase 1
- A Study of Pre-operative Metformin in Prostate CancerTerminatedNCT00881725Phase 2
- Examination of the Effects of Liraglutide on the Mode of Action of Insulin DetemirCompletedNCT00873223Phase 1
- Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With GemcitabineTerminatedNCT00867126Early Phase 1
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting ConditionsCompletedNCT00865852Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCompletedNCT00865839Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCompletedNCT00865748Phase 1
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCompletedNCT00865436Phase 1
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCompletedNCT00865241Phase 1
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting ConditionsCompletedNCT00865072Phase 1
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting ConditionsCompletedNCT00864734Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting ConditionsCompletedNCT00864669Phase 1
- Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial InfarctionCompletedNCT00863629Phase 4
- Levemir-Body Composition and Energy MetabolismCompletedNCT00862875Phase 4
- Medical Therapies for Chronic Post-Traumatic HeadachesTerminatedNCT00862095Phase 4
- Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 DiabetesCompletedNCT00860288Phase 2/3
- Insulin Glargine First Line vs Metformin in Type 2 Diabetic SubjectsCompletedNCT00857870Phase 4
- MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes MellitusCompletedNCT00854035Phase 3
- Effect of Sitagliptin on Graft Function Following Islet TransplantationTerminatedNCT00853944Phase 3
- Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous InsulinWithdrawnNCT00850161Phase 2
- Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to DysinsulinismCompletedNCT00847080Phase 4
- Metformin for Weight Control in Adolescents Taking Atypical AntipsychoticsStatus unknownNCT00845936Phase 4